Volume 90 Issue 46 | p. 17 | Concentrates
Issue Date: November 12, 2012

Shin-Etsu Acquires Drug Delivery Firm

Department: Business
Keywords: oncology, Japan, micelle, micellar, drug delivery

Shin-Etsu Chemical will spend $13 million to gain a majority stake in NanoCarrier, a Japanese drug delivery technology firm. NanoCarrier is developing drug-encapsulating micellar nanoparticles for use with oncology treatments. The company’s technology is based on research done by two professors at the University of Tokyo and Tokyo Women’s Medical University. Shin-Etsu will inject $8.5 million into NanoCarrier. It will also pay $4.5 million to the private equity firm Whiz Partners to acquire some of Whiz’s shares in NanoCarrier.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment